Larvol Delta - Biolojic-Design-Presents-New-Preclinical-Data-for-BD200-a-FirstinClass-MultibodyDrug-Conjugate-Targeting-Trop2-and-Nectin4-at-the-American-Association-of-Cancer-Research-Annual-Meeting

BD200 - Biolojic Design

https://www.globenewswire.com/news-release/2026/04/17/3276452/0/en/Biolojic-Design-Presents-New-Preclinical-Data-for-BD200-a-First-in-Class-Multibody-Drug-Conjugate-Targeting-Trop-2-and-Nectin-4-at-the-American-Association-of-Cancer-Research-Annua.html

Apr 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next